You are here: Industry Insights > flu vaccine

News List

Blue Cross Blue Shield of Massachusetts Urges Everyone to Get the Flu Vaccine prnewswire
December 20, 2021
Physicians at Blue Cross Blue Shield of Massachusetts (Blue Cross) encourage everyone to protect themselves, their family and friends from the flu this season by getting vaccinated.
mRNA-1010 quadrivalent flu vaccine shows promise in Phase I study EuropeanPharmaceuticalReview
December 15, 2021
Moderna’s quadrivalent flu vaccine mRNA-1010 boosted titres against all four strains 29 days after vaccination in young and older adults.
Flu Vaccine May Protect Against Adverse Events After SARS-CoV-2 August 18, 2021
Influenza vaccination has a potential protective effect against adverse events within 120 days of a positive severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) diagnosis, according to a study published online Aug. 3 in PLOS ONE.
‘Most comprehensive’ flu vaccination programme in UK history launching for winter 2021 pharmatimes
July 19, 2021
The government has announced that it will launch the ‘most comprehensive’ flu vaccination programme in UK history for winter 2021.
Sanofi and Translate Bio start clinical trial for mRNA flu vaccine expresspharma
June 23, 2021
The trial will evaluate the safety and immunogenicity of a monovalent flu vaccine candidate coding for the hemagglutinin protein of the A/H3N2 strain of the influenza virus.
Study demonstrates safety and efficacy of co-administering COVID-19 and flu vaccines pharmatimes
June 18, 2021
A study conducted by Novavax has found that co-administering a COVID-19 vaccine with a flu vaccine is safe and effective, with the efficacy of both jabs appearing to be preserved.
First-in-human universal flu vaccine trial begins europeanpharmaceuticalreview
June 03, 2021
The US National Institutes of Health have begun a first-in-human trial to assess the safety and immunogenicity of a potential universal influenza vaccine candidate, FluMos-v1.
BiondVax Universal Influenza Vaccine Candidate Trial Does Not Meet Primary, Secondary Endpoints americanpharmaceuticalreview
October 29, 2020
BiondVax Pharmaceuticals announced topline data from the Company's pivotal, phase 3 clinical trial of M-001 as a standalone universal flu vaccine candidate.
AstraZeneca ships first doses of flu vaccine pharmatimes
August 17, 2020
AstraZeneca has announced the first shipment of Flumist Quadrivalent vaccine doses have been sent to the US for the upcoming influenza season.
Researchers develop universal flu vaccine that protects against 6 influenza viruses in mice worldpharmanews
January 09, 2020
A novel nanoparticle vaccine that combines two major influenza proteins is effective in providing broad, long-lasting protection against influenza virus in mice, showing promise as a universal flu vaccine ...

Previous page 1 2 3 Next page